Related Experiment Video

Updated: Jun 5, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Bee venom reduces neuroinflammation in the MPTP-induced model of Parkinson's disease

Jong-In Kim1, Eun Jin Yang, Myeong Soo Lee

  • 1Department of Acupuncture and Moxibustion, College of Oriental Medicine, Kyung Hee University, Seoul, Republic of Korea.

The International Journal of Neuroscience
|January 27, 2011
PubMed
Abstract

Insights

Bee venom (BV) shows neuroprotective effects in a Parkinson's disease mouse model. BV treatment reduced inflammation and improved dopaminergic neuron survival, suggesting potential for Parkinson's disease therapy.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons.
  • Neuroinflammation, indicated by microglial activation, plays a crucial role in PD pathogenesis.
  • The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model mimics key features of PD, including dopaminergic neuron loss and inflammation.

Purpose of the Study:

  • To investigate the anti-inflammatory and neuroprotective effects of bee venom (BV) in an MPTP-induced mouse model of Parkinson's disease (PD).
  • To assess the impact of BV on dopaminergic neuron survival and microglial activation in the substantia nigra pars compacta (SNpc).

Main Methods:

  • Mice were administered MPTP via intraperitoneal injection to induce Parkinson's-like pathology.
  • Bee venom (BV) was administered subcutaneously.
  • Dopaminergic neuron loss was evaluated using tyrosine hydroxylase (TH) immunohistochemistry.
  • Microglial activation was assessed by quantifying macrophage antigen complex-1 (MAC-1) and inducible nitric oxide synthase (iNOS) expression.

Main Results:

  • MPTP treatment led to significant loss of dopaminergic neurons (32% survival on day 1, 46% on day 3).
  • BV treatment markedly improved dopaminergic neuron survival (70% on day 1, 78% on day 3).
  • BV administration reduced the expression of microglial activation markers (MAC-1 and iNOS) in the SNpc.

Conclusions:

  • Bee venom exhibits significant neuroprotective effects in the MPTP mouse model of Parkinson's disease.
  • BV treatment attenuates microglial activation, suggesting an anti-inflammatory mechanism.
  • These findings indicate that bee venom holds potential as a therapeutic agent for Parkinson's disease.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.